Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthma.
Allergy. 2019 Sep;74(9):1716-1726. doi: 10.1111/all.13850. Epub 2019 Jul 1.
Allergy. 2019.
PMID: 31049972
Free PMC article.
Clinical Trial.
Benefit of switching to mepolizumab from omalizumab in severe eosinophilic asthma based on patient characteristics.
Liu MC, Chipps B, Munoz X, Devouassoux G, Bergna M, Smith SG, Price RG, Galkin DV, Azmi J, Mouneimne D, Albers FC, Chapman KR.
Liu MC, et al. Among authors: mouneimne d.
Respir Res. 2021 May 10;22(1):144. doi: 10.1186/s12931-021-01733-9.
Respir Res. 2021.
PMID: 33971856
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite